Skip to content

BioLife Solutions BLFS Gross Unrealized Gains

Gross Unrealized Gains at other companies

Azenta logo
AzentaAZTA

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's gross unrealized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's gross unrealized gains?
BioLife Solutions (BLFS) reported gross unrealized gains of $31K in Q1 2026.
How has BioLife Solutions's gross unrealized gains changed year-over-year?
BioLife Solutions's gross unrealized gains decreased by 26.2% year-over-year, from $42K to $31K.
What is the long-term trend for BioLife Solutions's gross unrealized gains?
Over 3 years (2022 to 2025), BioLife Solutions's gross unrealized gains has grown at a 139.3% compound annual growth rate (CAGR), from $10K to $137K.